Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Yuen

Showing results (171-180 of 199) with videos related to

Pageof 20
Sort By:
Endoscopy|February 27, 2004
The role of cholecystectomy in reducing recurrent gallstone pancreatitisC K Hui, K C Lai, M F Yuen, et al.
Gut|May 8, 2007
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levelsM-F Yuen, Y Tanaka, N Shinkai, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infectionY K Yee, T K Cheung, K-M Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2016
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive declineAmy K Y Fu, Kwok-Wang Hung, Michael Y F Yuen, et al.
Journal of Nanoscience and Nanotechnology|August 22, 2012
Construction and evaluation of high-quality n-ZnO nanorod/p-diamond heterojunctionsC D Wang, S K Jha, Z H Chen, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2005
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongB Xia, H H X Xia, C W Ma, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2004
Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycinQ Gu, H H-X Xia, W H Wang, et al.
Histopathology|November 20, 2016
The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based studyKin-Long Chow, Ka-Yu Tse, Ching-Lung Cheung, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionW M Wong, Q Gu, S K Lam, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2002
Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the diseaseW-M Wong, S K Lam, W M Hui, et al.
Pageof 20

Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Endoscopy|February 27, 2004
The role of cholecystectomy in reducing recurrent gallstone pancreatitisC K Hui, K C Lai, M F Yuen, et al.
Gut|May 8, 2007
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levelsM-F Yuen, Y Tanaka, N Shinkai, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infectionY K Yee, T K Cheung, K-M Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2016
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive declineAmy K Y Fu, Kwok-Wang Hung, Michael Y F Yuen, et al.
Journal of Nanoscience and Nanotechnology|August 22, 2012
Construction and evaluation of high-quality n-ZnO nanorod/p-diamond heterojunctionsC D Wang, S K Jha, Z H Chen, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2005
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongB Xia, H H X Xia, C W Ma, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2004
Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycinQ Gu, H H-X Xia, W H Wang, et al.
Histopathology|November 20, 2016
The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based studyKin-Long Chow, Ka-Yu Tse, Ching-Lung Cheung, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2003
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionW M Wong, Q Gu, S K Lam, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2002
Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the diseaseW-M Wong, S K Lam, W M Hui, et al.
Pageof 20